Page 1 of Clinical Trials for Diffuse Large B-cell Lymphoma, 1035 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Prognostic Value of Clinical and Biological Factors in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma
Last Updated: June 8, 2011
Condition(s): Diffuse Large B-cell Lymphoma
2
Not yet recruiting
Study of AEB071 (a Protein Kinase C Inhibitor) in Patients With CD79-mutant Diffuse Large B-Cell Lymphoma
Last Updated: September 1, 2011
Condition(s): Diffuse Large B-Cell Lymphoma
3
Recruiting
Rituximab, Ifosfamide, Carboplatin, and Etoposide (RICE) Followed by Gallium Nitrate, Rituximab and Dexamethasone (GARD) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Last Updated: September 13, 2011
Condition(s): Diffuse Large B-cell Lymphoma
4
Completed
Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Last Updated: February 25, 2011
Condition(s): Diffuse Large B-Cell Lymphoma
5
Terminated
A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Last Updated: August 27, 2009
Condition(s): Diffuse Large B-cell Lymphoma
6
Recruiting
Prospective Cohort Study With Central Nervous System Evaluation in Diffuse Large B-cell Lymphoma
Last Updated: July 30, 2011
Condition(s): Diffuse Large B-cell Lymphoma
7
Recruiting
Feasibility Study Of Adding Bortezomib to R-ICE Chemotherapy To Treat Relapsed/ Refractory Diffuse Large B-Cell Lymphoma
Last Updated: November 21, 2010
Condition(s): Diffuse Large B-cell Lymphoma
8
Recruiting
Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Last Updated: November 3, 2011
Condition(s): Diffuse Large B-Cell Lymphoma; Lymphoma, Diffuse Large-Cell; Diffuse Large-Cell Lymphoma; Lymphoma
9
Recruiting
A Study to Evaluate the Safety and Efficacy of Dasatinib (Sprycel) in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Last Updated: January 3, 2011
Condition(s): Diffuse Large B-cell Lymphoma
10
Suspended
GCS-100 in Combination With Etoposide and Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Last Updated: May 15, 2009
Condition(s): Diffuse Large B-Cell Lymphoma, Relapsed or Refractory
11
Recruiting
Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy
Last Updated: May 24, 2011
Condition(s): Diffuse Large B-cell Lymphoma
12
Recruiting
Oblimersen Sodium and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
Last Updated: March 1, 2011
Condition(s): Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma
13
Recruiting
Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
Last Updated: January 11, 2012
Condition(s): Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
14
Recruiting
Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)
Last Updated: December 23, 2011
Condition(s): Hodgkin's Disease; Lymphoma
15
Active, not recruiting
Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma
Last Updated: September 8, 2010
Condition(s): Diffuse Large B-cell Lymphoma
16
Recruiting
Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
Last Updated: January 11, 2012
Condition(s): Diffuse Large B Cell Lymphoma
17
Recruiting
DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma
Last Updated: February 11, 2010
Condition(s): Diffuse Large B-Cell Lymphoma (DLBCL)
18
Suspended
GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
Last Updated: October 22, 2007
Condition(s): Lymphoma
19
Completed
Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma
Last Updated: November 15, 2011
Condition(s): Diffuse Large B-cell Lymphoma
20
Recruiting
Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma
Last Updated: January 13, 2012
Condition(s): Burkitt Lymphoma; Diffuse Large B-cell Lymphoma, c-MYC Positive

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Diffuse+Large+B-cell+Lymphoma

Page 1 of Clinical Trials for Diffuse Large B-cell Lymphoma, 1035 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About